Eagle Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-482,719
| Closed | -$11.4M | – | 672 |
|
|
2016
Q2 | $11.4M | Sell |
482,719
-218,228
| -31% | -$5.15M | 0.08% | 306 |
|
|
2016
Q1 | $14.3M | Sell |
700,947
-521,533
| -43% | -$10.6M | 0.1% | 275 |
|
|
2015
Q4 | $62.9M | Sell |
1,222,480
-12,123
| -1% | -$624K | 0.42% | 76 |
|
|
2015
Q3 | $52.6M | Sell |
1,234,603
-236,565
| -16% | -$10.1M | 0.36% | 86 |
|
|
2015
Q2 | $67M | Buy |
1,471,168
+5,368
| +0.4% | +$245K | 0.38% | 95 |
|
|
2015
Q1 | $55.6M | Sell |
1,465,800
-162,113
| -10% | -$6.15M | 0.32% | 112 |
|
|
2014
Q4 | $46.1M | Sell |
1,627,913
-101,545
| -6% | -$2.88M | 0.27% | 133 |
|
|
2014
Q3 | $43.7M | Buy |
1,729,458
+110,937
| +7% | +$2.8M | 0.25% | 143 |
|
|
2014
Q2 | $47.2M | Buy |
1,618,521
+467,107
| +41% | +$13.6M | 0.26% | 134 |
|
|
2014
Q1 | $29.8M | Buy |
+1,151,414
| New | +$29.8M | 0.16% | 190 |
|